Literature DB >> 6776242

Distribution of leukocytes labeled with In-111 oxine in dogs with acute inflammatory lesions.

J G McAfee, G M Gagne, G Subramanian, Z D Grossman, F D Thomas, M L Roskopf, P Fernandes, B J Lyons.   

Abstract

The biodistributions of In-111 oxine (with and without leukocyte labeling) of Ga-67 citrate and of In-111 chloride were compared in 30 dogs with chemical and bacterial abscesses and acute joint inflammation. Serial blood samples were taken and tissues radioassayed at 24 hr. The concentration of In-111-oxine leukocytes in all three types of inflammatory lesion was invariably much higher than that of Ga-67 injected simultaneously. For bacterial abscesses, the mean abscess-to-muscle concentration ratio was 3,000 for labeled leukocytes and 72 for Ga-67. Aqueous buffered In-111 oxine sulfate solution appeared better for labeling leukocytes than In-111 oxine in ethanol. When In-111 oxine was not incubated with leukocytes before injection, or if the cells were poorly labeled or damaged, the abscess localization was often inferior to that of gallium. Localization of In-111 chloride also appeared inferior to that of gallium. No significant difference in distribution in the major organs or inflammatory lesions was demonstrable between labeled suspensions of "pure"neutrophils harvested by elutriation and "mixed"cell suspensions of leukocytes after erythrocyte sedimentation with hydroxyethyl starch. For both types of leukocyte suspension labeled with In-111 oxine, the average recovery of cell-bound activity in the circulating blood at 4 hr was 32% of the administered activity, inferior to that of DFP-32. It is concluded, therefore, that In-111 oxine is a more effective agent than Ga-67 for the detection of acute focal inflammatory lesions if leukocytes are properly labeled, but current techniques are unsatisfactory for the study of neutrophil kinetics.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776242

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  A functional comparison of IIIindium-labelled elicited peripheral blood neutrophils and peritoneal neutrophils in the rat.

Authors:  J A Savige; S H Saverymuttu; A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

2.  Leucocyte sequestration in endotoxemia and the effect of low-molecular-weight dextran.

Authors:  J T Christenson; A Owunwanne
Journal:  Eur J Nucl Med       Date:  1990

3.  Dynamic properties of blood flow and leukocyte mobilization in infected flaps.

Authors:  L J Feng; D C Price; S J Mathes; D Hohn
Journal:  World J Surg       Date:  1990 Nov-Dec       Impact factor: 3.352

Review 4.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Functional alterations of human platelets following indium-111 labelling using different incubation media and labelling agents.

Authors:  Y Isaka; K Kimura; M Matsumoto; T Kamada; M Imaizumi
Journal:  Eur J Nucl Med       Date:  1991

6.  Photopenic defects in marrow-containing skeleton on indium-111 leucocyte scintigraphy: prevalence at sites suspected of osteomyelitis and as an incidental finding.

Authors:  A F Jacobson; C P Gilles; M D Cerqueira
Journal:  Eur J Nucl Med       Date:  1992

Review 7.  The contribution of nuclear medicine to the patient with infection.

Authors:  W Becker
Journal:  Eur J Nucl Med       Date:  1995-10

8.  Indium-111-labeled autologous leukocyte imaging and fecal excretion. Comparison with conventional methods of assessment of inflammatory bowel disease.

Authors:  D J Leddin; W G Paterson; L R DaCosta; P K Dinda; W T Depew; J Markotich; J P McKaigney; A Groll; I T Beck
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

9.  99mTc-HM-PAO for leukocyte labeling--experimental comparison with 111In oxine in dogs.

Authors:  J G McAfee; G Subramanian; G Gagne; R F Schneider; C Zapf-Longo
Journal:  Eur J Nucl Med       Date:  1987
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.